Pfizer Strengthens Commitment To I-many's Contract Management Solutions

I-many, Inc., a leading provider of contract management software and services for the enterprise, announced that Pfizer, an I-many customer since 1991, has licensed core next generation solutions of the I-many Contract Management Suite for Life Sciences, which include I-many CARS NG, I-many Medicaid Rebates, and I-many Validata.

Pfizer is also contributing its industry knowledge to assist with additional product development, enabling I-many to add valuable new contract management functionalities to the I-many Contract Management Suite for Life Sciences and bring these core functions to market in upcoming versions in a shorter time span.

"Pfizer's commitment to I-many demonstrates how important effective contract management has become to improving operational efficiency and profitability," said David Blumberg, executive vice president of fulfillment services at I-many. "Pfizer's investment in our product development shows the value Pfizer places on our technology and capabilities, as well as the strength of our long-term relationship."

John Rade, president and CEO of I-many added, "Pfizer has been an ideal customer and partner to I-many for many years, and we're excited they will now enjoy the most state-of-the-art solution available today for contract management. We look forward to further developing our relationship."

The I-many Contract Management Suite for Life Sciences directly addresses the challenges faced by life sciences companies as they navigate complex regulatory environments. I-many is one of the first providers in the industry to deliver specialized analytic solutions that allow life sciences companies to gain insight into the often sweeping effects of their past, current and future contracts. This advanced insight allows them to adjust corporate strategies in order to better forecast and optimize performance.

About I-many Contract Management Suite for Life Sciences
The core modules of the I-many Contract Management Suite for Life Sciences include several solutions specifically developed to handle the industry's most pressing issues. All the modules are built on a common foundation, I-many Enterprise Contract Management Framework (ECMF), which combines enterprise-class security, robust and scalable J2EE platforms and an industry standard database aligned in a true service-oriented architecture (SOA). Because I-many ECMF allows all information, including metadata and documents, to be stored, accessed and managed using a common infrastructure across all its modules, the solution enables users to capture data once and use it repeatedly across the enterprise.

The I-many Contract Management Suite for Life Sciences includes I-many Contract Manager, I-many CARS NG, I-many Medicaid Rebates, I-many Government Pricing, I-many Validata, I-many Medicaid Analytics and I-many CARS BI.

About Pfizer
Pfizer is the world's largest research-based biomedical and pharmaceutical company. Every day, approximately 87,000 colleagues in more than 150 countries work to discover, develop, manufacture and deliver quality, safe and effective prescription medicines to patients Its corporate headquarters are located in New York, with major research and development locations in the United States and England. Recent innovations include Sutent a novel cancer medicine that both cuts off the blood supply that feeds tumors and destroys cellular reproduction, and Chantix a new prescription medicine and accompanying support plan designed specifically to help smokers quit.

In 2006, Pfizer earned $48.4B in revenues and invested $7.6B in research and development. For more information about Pfizer, go to www.pfizer.com.

About I-many
I-many is the leading provider of contract management software and services for the enterprise. With hundreds of customers across 21 industries worldwide, I-many is enabling businesses to manage the entire contract life cycle, from pre-contract processes and contract management to active compliance and contract optimization. The result is an end-to-end solution that provides greater levels of insight into contract performance, allowing companies to improve profitability and achieve a measurable return on investment. For more information, please visit www.imany.com.

SOURCE: I-many, Inc.